Verition Fund Management LLC Trims Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Verition Fund Management LLC trimmed its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 47.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,471 shares of the medical instruments supplier's stock after selling 66,114 shares during the period. Verition Fund Management LLC's holdings in DENTSPLY SIRONA were worth $2,015,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. First Eagle Investment Management LLC increased its position in DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier's stock valued at $325,571,000 after purchasing an additional 3,283,965 shares during the period. Dimensional Fund Advisors LP lifted its holdings in DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier's stock worth $110,118,000 after buying an additional 1,308,411 shares during the period. Cooke & Bieler LP boosted its position in DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier's stock valued at $186,996,000 after acquiring an additional 1,046,105 shares in the last quarter. National Bank of Canada FI grew its holdings in shares of DENTSPLY SIRONA by 684.6% during the 2nd quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier's stock worth $21,586,000 after acquiring an additional 764,700 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of DENTSPLY SIRONA by 50.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock worth $55,900,000 after acquiring an additional 692,100 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 1.2 %

Shares of XRAY stock traded down $0.23 during mid-day trading on Friday, hitting $19.08. The company's stock had a trading volume of 1,628,120 shares, compared to its average volume of 3,097,752. The stock has a market cap of $3.79 billion, a price-to-earnings ratio of -9.22, a PEG ratio of 1.91 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $37.60. The business has a 50-day moving average price of $21.86 and a 200 day moving average price of $24.49.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA's revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.49 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Needham & Company LLC decreased their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a report on Friday, October 25th. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a report on Friday, November 8th. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a report on Tuesday. Finally, Evercore ISI cut their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 8th. Eight equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of "Hold" and an average price target of $28.40.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.